trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] Incorporated in PLGA Nanoparticles for the Delivery of Nitric Oxide to B16-F10 Cells: Cytotoxicity and Phototoxicity

被引:33
作者
Gomes, Anderson J. [1 ]
Espreafico, Enilza M. [2 ]
Tfouni, Elia [3 ]
机构
[1] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
ruthenium nitrosyl; nitric oxide; nanoparticles; PLGA; cytotoxicity; phototoxicity; B16-F10; cyclam; Hedta; nitric oxide donors; RUTHENIUM COMPLEXES; PHOTOCHEMICAL-REACTIONS; BACTERIOCHLOROPHYLL-A; BIOLOGICAL-ACTIVITY; ANTICANCER DRUGS; CELLULAR UPTAKE; IN-VITRO; NO; RELEASE; MICROPARTICLES;
D O I
10.1021/mp3005534
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The immobilization and characterization of trans-[Ru(NO)Cl(cyclam)](PF6)(2) (cyclam = 1,4,8,11-tetraazacyclotetradecane), and [Ru(NO)(Hedta)] (Hedta = ethylenediaminetetraacetic acid) entrapped in poly(D,L-lactic-co-glycolic) acid (PLGA) nanoparticles (NP) using the double emulsification process is described. Scanning electron microscopy and dynamic light scattering revealed that the particles are spherical in shape, have a size distribution between 220 and 840 nm of diameter, and have a tendency to aggregate confirmed by a zeta potential between -3.2 and +3.5 mV. Using this method the loading efficiency was 26% for trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 32% for [Ru(NO)(Hedta)]. The release of the complexes from the NPs shows that cyclam-NP and Hedta-NP exhibited a two-phase exponential association release pattern, which was characterized by an initial complex burst during the first 24 h, followed by a slower release phase complex profile, due to a few pores observed in surface of nanoparticles using atomic force microscopy. The in vitro cytotoxic activity of the nitrosyl complexes in solution and incorporated in PLGA nanoparticles on melanoma cancer cells (cell line B16-F10) was investigated. The lower cytotoxicity of trans-[RuCl(cyclam)(NO)](2+) (12.4 +/- 2.6%) and [Ru(NO)(Hedta)] (4.0 +/- 2.7%) in solution compared to that of trans-[Ru(NO)(NH3)(4)py](3+) (46.1 +/- 6.4%) is consistent with the rate constant release of NO of these complexes (k(-NO) = 6.2 x 10(-4) s(-1), 2.0 x 10(-3) s(-1), and 6.0 x 10(-2) s(-1), respectively); the cytotoxicities are also inhibited in the presence of the NO scavenger carboxy-PTIO. The phototoxicity of these complexes is due to NO release, which lead to 53.8 +/- 6.2% of cell death in the. presence of trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 22.3 +/- 5.1% in the presence of [Ru(NO)(Hedta)]. The PLGA nanoparticles loaded with trans-[Ru(NO)Cl(cyclam)](PF6)(2) and [Ru(NO)(Hedta)] exerted in vitro a reduced activity against melanoma cells when compared to the activity of complex in solution (nonentrapped in nanoparticles). Blank PLGA nanoparticles did not exhibit cytotoxicity. In the presence of light and of ruthenium nitrosyl complexes or cyclam-NP and Hedta-NP, B16-F10 cells displayed a considerable damage of the surface with rupture of the plasma membrane. This behavior is an indicative of the efficiency of the DDS to deliver the NO from the entrapped complex when photoinduced.
引用
收藏
页码:3544 / 3554
页数:11
相关论文
共 89 条
  • [1] ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION
    AKAIKE, T
    YOSHIDA, M
    MIYAMOTO, Y
    SATO, K
    KOHNO, M
    SASAMOTO, K
    MIYAZAKI, K
    UEDA, S
    MAEDA, H
    [J]. BIOCHEMISTRY, 1993, 32 (03) : 827 - 832
  • [2] Ruthenium antimetastatic agents
    Alessio, E
    Mestroni, G
    Bergamo, A
    Sava, G
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (15) : 1525 - 1535
  • [3] Allardyce CS, 2001, PLATIN MET REV, V45, P62
  • [4] Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy
    Ang, Wee Han
    Dyson, Paul J.
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) : 4003 - 4018
  • [5] Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds
    Benedetti, Brad T.
    Quintal, Susana
    Farrell, Nicholas P.
    [J]. DALTON TRANSACTIONS, 2011, 40 (41) : 10983 - 10988
  • [6] 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity
    Bratsos, Ioannis
    Urankar, Damijana
    Zangrando, Ennio
    Genova-Kalou, Petia
    Kosmrlj, Janez
    Alessio, Enzo
    Turel, Iztok
    [J]. DALTON TRANSACTIONS, 2011, 40 (19) : 5188 - 5199
  • [7] trans-platinum planar amine compounds with [N2O2] ligand donor sets:: Effects of carboxylate leaving groups and steric hindrance on chemical and biological properties
    Bulluss, Genevieve H.
    Knott, Kenneth M.
    Ma, Erin S. F.
    Aris, Sheena M.
    Alvarado, Eugenio
    Farrell, Nicholas
    [J]. INORGANIC CHEMISTRY, 2006, 45 (15) : 5733 - 5735
  • [8] Ruthenium(III) polyaminocarboxylate complexes: Efficient and effective nitric oxide scavengers
    Cameron, BR
    Darkes, MC
    Yee, H
    Olsen, M
    Fricker, SP
    Skerlj, RT
    Bridger, GJ
    Davies, NA
    Wilson, MT
    Rose, DJ
    Zubieta, J
    [J]. INORGANIC CHEMISTRY, 2003, 42 (06) : 1868 - 1876
  • [9] Photochemical reactions of trans-[Ru(NH3)4L(NO)]3+ complexes
    Carlos, RM
    Ferro, AA
    Silva, HAS
    Gomes, MG
    Borges, SSS
    Ford, PC
    Tfouni, E
    Franco, DW
    [J]. INORGANICA CHIMICA ACTA, 2004, 357 (05) : 1381 - 1388
  • [10] Nitric oxide release: Part II. Therapeutic applications
    Carpenter, Alexis W.
    Schoenfisch, Mark H.
    [J]. CHEMICAL SOCIETY REVIEWS, 2012, 41 (10) : 3742 - 3752